Calendar Immunocore Holdings plc

Equities

IMCR

US45258D1054

Market Closed - Nasdaq 04:00:00 2024-04-12 pm EDT 5-day change 1st Jan Change
56.53 USD -4.30% Intraday chart for Immunocore Holdings plc -10.98% -17.26%

Chart calendar Immunocore Holdings plc

6e9bada9b596495.Tp1mpWdKSs5wat6xFn02fK8iQgq7zD_2_jyOAaqx0RM.LdgM4BdzGvs3LJDFUgcDPvd2JWOJgnagh2_IVOfyq1Ua8QXLHgQ5txEtqQ~3f3842444c50f87f040e65e7773bfb2f

Upcoming events on Immunocore Holdings plc

2024-04-15 Van Lanschot Kempen Life Sciences Conference
2024-04-25 04:00 pm Canaccord Horizons in Oncology Conference
2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-25 Q4 2024 Earnings Release (Projected)

Past events on Immunocore Holdings plc

2024-04-10 11:00 am Needham Healthcare Conference - Fireside Chat
2024-03-14 09:30 am Barclays Global Healthcare Conference - Fireside Chat
2024-03-12 Jefferies Biotech on the Bay Summit
2024-03-11 Leerink Partners Global Biopharma Conference
2024-03-05 04:30 pm Retroviruses and Opportunistic Infections Conference - Poster No D5
2024-03-05 11:10 am TD Cowen Health Care Conference - Fireside Chat
2024-03-04 04:30 pm Retroviruses and Opportunistic Infections Conference - Poster No D6
2024-02-28 08:00 am Q4 2023 Earnings Call
2024-02-28 07:00 am Q4 2023 Earnings Release
2024-01-10 12:00 pm JPMorgan Healthcare Conference
2023-11-27 10:30 am BTIG Ophthalmology Day
2023-11-14 05:30 am Jefferies London Healthcare Conference
2023-11-07 Truist Securities Healthcare Conference
2023-11-07 07:00 am Q3 2023 Earnings Release
2023-11-05 Society for Melanoma Research Congress - Poster No: P: 163
2023-11-05 Society for Melanoma Research Congress - Poster No: P: 089
2023-11-05 Society for Melanoma Research Congress - Poster No: P-225
2023-11-05 Society for Melanoma Research Congress - Poster No: P-096
2023-11-05 Society for Melanoma Research Congress - Poster No: P: 047
2023-11-03 Society for Immunotherapy of Cancer Meeting - Abstract No: 1108

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP
Released
Forecast
Spread
25,7


30,1
26,9
12.02%
26,5
25,7
3.18%
144
139
3.22%
197
196
0.38%

229

EBITDA
Million GBP
Released
Forecast
Spread
0,00


-82,7
-74,1
-11.68%
-130
-134
3.45%
-33,5
-4,89
-584.59%
-43,9
-43,8
-0.19%

-68,7

EBIT
Million GBP
Released
Forecast
Spread
0,00


-86,2
-89,5
3.67%
-135
-137
1.38%
-39,6
-17,6
-125.47%
-47,1
-50,5
6.67%

-73,5

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
0,00


-87,4
-93,1
6.15%
-141
-140
-0.81%
-44,1
-23,9
-84.39%
-48,1
-39,4
-22.14%

-63,5

Net income
Million GBP
Released
Forecast
Spread
-104


-74,1
-65,4
-13.28%
-132
-128
-2.83%
-41,2
-17,4
-137.3%
-43,7
-39,8
-9.69%

-71,4

EPS
GBP
Released
Forecast
Spread
0,00


-2,79
-8,44
66.96%
-3,10
-2,99
-3.77%
-0,90
-0,39
-127.99%
-0,89
-0,80
-11.11%

-1,24

Announcement Date07/05/2025/03/2103/03/2201/03/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million GBP
Released
Forecast
Spread
6,59
5,61
17.47%
22,5
6,47
247.63%
32,0
17,3
84.77%
41,2
30,3
36.08%
48,1
44,9
6.93%
44,5
41,3
7.73%
47,8
46,2
3.35%
51,5
50,6
1.68%
55,4
53,1
4.47%

54,8


56,8


58,0


59,9


62,8

EBITDA
Million GBP
Released
Forecast
Spread
-36,5
-34,0
-7.4%
-14,8
-37,5
60.58%
-5,36
-31,0
82.73%
7,65
-16,0
147.81%
-21,0
10,1
-307.81%
-16,1
3,70
-535.19%
-14,5
-21,5
32.76%
0,67
-20,6
103.25%
-13,4
-18,0
25.46%

-15,5


-15,7


-17,0


-24,9




EBIT
Million GBP
Released
Forecast
Spread
-37,8
-37,6
-0.67%
-16,5
-38,9
57.68%
-6,99
-26,8
73.93%
6,17
-17,3
135.61%
-22,3
-0,89
-2411.76%
-17,4
-14,1
-23.52%
-15,8
-16,6
4.71%
-0,70
-14,4
95.16%
-13,5
-11,6
-15.93%

-15,0


-16,3


-17,1


-19,5


-17,8

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
-39,2
-37,4
-4.69%
-17,8
-40,1
55.61%
-8,27
-27,3
69.7%
4,98
-15,2
132.78%
-23,1
-2,46
-838.09%
-16,5
-13,0
-26.76%
-13,9
-17,1
18.38%
1,76
-14,7
111.99%
-20,3
-10,7
-88.57%

-13,6


-14,9


-16,2


-18,8


-19,4

Net income
Million GBP
Released
Forecast
Spread
-39,4
-35,4
-11.4%
-16,1
-38,0
57.55%
-6,12
-25,9
76.37%
6,23
-12,8
148.64%
-25,2
-1,00
-2423.25%
-16,7
-14,4
-16.02%
-14,1
-16,5
14.79%
1,90
-14,6
113.02%
-15,6
-10,5
-48.72%

-13,9


-14,9


-15,7


-17,5


-19,0

EPS
GBP
Released
Forecast
Spread
-0,90
-0,80
-12.17%
-0,37
-0,86
56.99%
-0,14
-0,57
75.62%
0,12
-0,28
143.3%
-0,54
-0,02
-2267.38%
-0,35
-0,30
-17.42%
-0,29
-0,34
14.23%
0,04
-0,30
113.52%
-0,32
-0,21
-49.07%

-0,29


-0,29


-0,31


-0,33


-0,37

Announcement Date03/03/2211/05/2210/08/2209/11/2201/03/2310/05/2310/08/2307/11/2328/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMCR Stock
  4. Calendar Immunocore Holdings plc